AC
CYTK icon

Athanor Capital’s Cytokinetics CYTK Stock Holding History

Athanor Capital’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9,986
Closed -$232K – 513
2021
Q1 		$232K Sell
9,986
-15,663
-61% -$334K 0.01% 655
2020
Q4 		$533K Buy
+25,649
New +$469K 0.01% 453
2020
Q3 		– Sell
-41,696
Closed -$983K – 566
2020
Q2 		$983K Buy
+41,696
New +$782K 0.05% 193
2020
Q1 		– Sell
-45,589
Closed -$484K – 201
2019
Q4 		$484K Sell
45,589
-15,911
-26% -$163K 0.02% 247
2019
Q3 		$700K Buy
61,500
+40,000
+186% +$502K 0.05% 134
2019
Q2 		$242K Buy
+21,500
New +$207K 0.03% 119

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Athanor Capital's CYTK Position: Q2 2021 in Review

Athanor Capital sold out of Cytokinetics (CYTK) in Q2 2021, closing a stake of 9,986 shares — an estimated $232K sold.

Athanor Capital first reported a position in CYTK in Q2 2019 and held it in 6 quarters. The position peaked at $983K in Q2 2020. 190 funds tracked by Wall St. Rank hold CYTK as of Q2 2021.

  • Athanor Capital reported no remaining Cytokinetics position as of Q2 2021 after selling out during the quarter.
  • Athanor Capital sold 9,986 Cytokinetics shares in Q2 2021, an estimated $232K.
  • Athanor Capital first reported a position in Cytokinetics in Q2 2019 and held it in 6 quarters.
  • Athanor Capital's Cytokinetics position peaked at $983K in Q2 2020.
  • 190 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2021.

Based on Athanor Capital's 13F filing for Q2 2021, filed 16 Aug 2021.